{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:40:20Z","timestamp":1793889620971,"version":"4.8.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Regional Collaborative Innovation Special Project of the Autonomous Region, Science and Technology Support Program for Xinjiang","award":["2024E02054"],"award-info":[{"award-number":["2024E02054"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360476"],"award-info":[{"award-number":["82360476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Projects of Xinjiang Uyghur Autonomous Region","award":["2022D01D39"],"award-info":[{"award-number":["2022D01D39"]}]},{"name":"Excellence Youth Science Foundation of Xinjiang Uyghur Autonomous Region","award":["2023D01E05"],"award-info":[{"award-number":["2023D01E05"]}]},{"name":"Xinjiang Uyghur Autonomous Region \"Tianshan Talents\" youth science and technology top talent project","award":["2022TSYCCX0026"],"award-info":[{"award-number":["2022TSYCCX0026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13839-0","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T16:31:26Z","timestamp":1745857886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of non-insulin-based insulin resistance indices, mean platelet volume and prostate cancer: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengqing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"13839_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"13839_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020201","volume":"8","author":"K Fujita","year":"2019","unstructured":"Fujita K, Hayashi T, Matsushita M, et al. Obesity, inflammation, and prostate cancer. J Clin Med. 2019;8: 201.","journal-title":"J Clin Med"},{"key":"13839_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/MOU.0000000000001041","volume":"32","author":"F Belladelli","year":"2022","unstructured":"Belladelli F, Montorsi F, Martini A. Metabolic syndrome, obesity and cancer risk. Curr Opin Urol. 2022;32:594\u20137.","journal-title":"Curr Opin Urol"},{"key":"13839_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","volume":"63","author":"EH Allott","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63:800\u20139.","journal-title":"Eur Urol"},{"key":"13839_CR5","doi-asserted-by":"publisher","first-page":"1442740","DOI":"10.3389\/fendo.2024.1442740","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Apizi A, Qiu H, et al. Association between metabolic obesity phenotypes and the risk of developing prostate cancer: a propensity score matching study based on Xinjiang. Front Endocrinol (Lausanne). 2024;15:1442740.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13839_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.euf.2021.04.022","volume":"7","author":"K Lifshitz","year":"2021","unstructured":"Lifshitz K, Ber Y, Margel D. Role of metabolic syndrome in prostate cancer development. Eur Urol Focus. 2021;7:508\u201312.","journal-title":"Eur Urol Focus"},{"key":"13839_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12020-012-9702-3","volume":"43","author":"R Karnchanasorn","year":"2013","unstructured":"Karnchanasorn R, Ou HY, Chuang LM, et al. Insulin resistance is not necessarily an essential element of metabolic syndrome. Endocrine. 2013;43:92\u20139.","journal-title":"Endocrine"},{"key":"13839_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4239\/wjd.v11.i6.227","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Yang Y, Liao Z. Diabetes and cancer: Epidemiological and biological links. World J Diabetes. 2020;11:227\u201338.","journal-title":"World J Diabetes"},{"key":"13839_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335.","journal-title":"Metabolism"},{"key":"13839_CR10","doi-asserted-by":"publisher","first-page":"13732","DOI":"10.1002\/cam4.6004","volume":"12","author":"SHJ Jochems","year":"2023","unstructured":"Jochems SHJ, Fritz J, H\u00e4ggstr\u00f6m C, et al. Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study. Cancer Med. 2023;12:13732\u201344.","journal-title":"Cancer Med"},{"key":"13839_CR11","doi-asserted-by":"crossref","unstructured":"Zheng R, Daniels JP, Moreira DM, et al. Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. Cancer. 2025;131:e35568.","DOI":"10.1002\/cncr.35568"},{"key":"13839_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.dsx.2018.08.031","volume":"13","author":"S Saboori","year":"2019","unstructured":"Saboori S, Rad EY, Birjandi M, et al. Serum insulin level, HOMA-IR and prostate cancer risk: a systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13:110\u20135.","journal-title":"Diabetes Metab Syndr"},{"key":"13839_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/carcin\/bgac013","volume":"43","author":"H Wang","year":"2022","unstructured":"Wang H, Yan W, Sun Y, et al. High-fat diet-induced hyperinsulinemia promotes the development of prostate adenocarcinoma in prostate-specific Pten-\/- mice. Carcinogenesis. 2022;43:504\u201316.","journal-title":"Carcinogenesis"},{"key":"13839_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41416-023-02526-1","volume":"130","author":"J Fritz","year":"2024","unstructured":"Fritz J, Jochems SHJ, Bj\u00f8rge T, et al. Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts. Br J Cancer. 2024;130:308\u201316.","journal-title":"Br J Cancer"},{"key":"13839_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011771","volume":"97","author":"ZL Guo","year":"2018","unstructured":"Guo ZL, Weng XT, Chan FL, et al. Serum C-peptide concentration and prostate cancer: a meta-analysis of observational studies. Medicine (Baltimore). 2018;97: e11771.","journal-title":"Medicine (Baltimore)"},{"key":"13839_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jch.14155","volume":"23","author":"HV Minh","year":"2021","unstructured":"Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich). 2021;23:529\u201337.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"13839_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep16494","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Xu C, Xun Y, et al. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5: 16494.","journal-title":"Sci Rep"},{"key":"13839_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu16213718","volume":"16","author":"S Haidar","year":"2024","unstructured":"Haidar S, Mahboub N, Papandreou D, et al. Triglyceride and Glucose Index as an Optimal Predictor of Metabolic Syndrome in Lebanese Adults. Nutrients. 2024;16: 3718.","journal-title":"Nutrients"},{"key":"13839_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13098-023-00988-0","volume":"15","author":"M Tohidi","year":"2023","unstructured":"Tohidi M, Asgari S, Chary A, et al. Association of triglycerides to high-density lipoprotein cholesterol ratio to identify future prediabetes and type 2 diabetes mellitus: over one-decade follow-up in the Iranian population. Diabetol Metab Syndr. 2023;15:13.","journal-title":"Diabetol Metab Syndr"},{"key":"13839_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13098-024-01307-x","volume":"16","author":"Q Shangguan","year":"2024","unstructured":"Shangguan Q, Liu Q, Yang R, et al. Predictive value of insulin resistance surrogates for the development of diabetes in individuals with baseline normoglycemia: findings from two independent cohort studies in China and Japan. Diabetol Metab Syndr. 2024;16:68.","journal-title":"Diabetol Metab Syndr"},{"key":"13839_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00592-016-0878-5","volume":"53","author":"B Ji","year":"2016","unstructured":"Ji B, Qu H, Wang H, et al. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population. Acta Diabetol. 2016;53:817\u201323.","journal-title":"Acta Diabetol"},{"key":"13839_CR22","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2147\/DMSO.S425469","volume":"16","author":"A Kelem","year":"2023","unstructured":"Kelem A, Adane T, Shiferaw E. Insulin Resistance-Induced Platelet Hyperactivity and a Potential Biomarker Role of Platelet Parameters: A Narrative Review. Diabetes Metab Syndr Obes. 2023;16:2843\u201353.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"13839_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/0953710042000267707","volume":"15","author":"N Papanas","year":"2004","unstructured":"Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15:475\u20138.","journal-title":"Platelets"},{"key":"13839_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025303","volume":"100","author":"Q Ding","year":"2021","unstructured":"Ding Q, Wang F, Guo X, et al. The relationship between mean platelet volume and metabolic syndrome in patients with type 2 diabetes mellitus: A retrospective study. Medicine (Baltimore). 2021;100: e25303.","journal-title":"Medicine (Baltimore)"},{"key":"13839_CR25","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7-12.","journal-title":"J Am Coll Cardiol"},{"key":"13839_CR26","doi-asserted-by":"publisher","DOI":"10.2174\/1573399817666210608121024","volume":"17","author":"AE Mi","year":"2021","unstructured":"Mi AE, Abdallah N, Eldars W. Mean Platelet Volume and Platelet Distribution Width Correlate with Microvascular Complications in Egyptian People with Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2021;17: e080621193947.","journal-title":"Curr Diabetes Rev"},{"key":"13839_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12933-024-02177-3","volume":"23","author":"V Cassano","year":"2024","unstructured":"Cassano V, Armentaro G, Iembo D, et al. Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis\u202f: Platelets in cardiovascular risk. Cardiovasc Diabetol. 2024;23:89.","journal-title":"Cardiovasc Diabetol"},{"key":"13839_CR28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/cancers11071022","volume":"11","author":"N Pavlovic","year":"2019","unstructured":"Pavlovic N, Rani B, Gerwins P, Heindryckx F. Platelets as Key Factors in Hepatocellular Carcinoma. Cancers (Basel). 2019;11:1022.","journal-title":"Cancers (Basel)"},{"key":"13839_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.845288","volume":"9","author":"W Song","year":"2022","unstructured":"Song W, Ding N, Zhang X, et al. Mean Platelet Volume Enhances the Diagnostic Specificity of PSA for Prostate Cancer. Front Surg. 2022;9: 845288.","journal-title":"Front Surg"},{"key":"13839_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0034-1370767","volume":"40","author":"HA Goubran","year":"2014","unstructured":"Goubran HA, Stakiw J, Radosevic M, et al. Platelet-cancer interactions. Semin Thromb Hemost. 2014;40:296\u2013305.","journal-title":"Semin Thromb Hemost"},{"key":"13839_CR31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/ijms21030788","volume":"21","author":"MV Catani","year":"2020","unstructured":"Catani MV, Savini I, Tullio V, Gasperi V. The, \u201cJanus Face\u201d of platelets in cancer. Int J Mol Sci. 2020;21:788.","journal-title":"Int J Mol Sci"},{"key":"13839_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s40001-023-01342-w","volume":"28","author":"L Zhou","year":"2023","unstructured":"Zhou L, Zhang Z, Tian Y, et al. The critical role of platelet in cancer progression and metastasis. Eur J Med Res. 2023;28:385.","journal-title":"Eur J Med Res"},{"key":"13839_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644035","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med. 2021;8: 644035.","journal-title":"Front Cardiovasc Med"},{"key":"13839_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2023.2195996","volume":"45","author":"Q Yi","year":"2023","unstructured":"Yi Q, Hu H, Zeng Q. Association of triglycerides to high density lipoprotein cholesterol ratio with hypertension in Chinese adults: a cross-sectional study. Clin Exp Hypertens. 2023;45: 2195996.","journal-title":"Clin Exp Hypertens"},{"key":"13839_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178:533\u201344.","journal-title":"Eur J Endocrinol"},{"key":"13839_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41585-021-00476-y","volume":"18","author":"JS Kim","year":"2021","unstructured":"Kim JS, Galv\u00e3o DA, Newton RU, et al. Exercise-induced myokines and their effect on prostate cancer. Nat Rev Urol. 2021;18:519\u201342.","journal-title":"Nat Rev Urol"},{"key":"13839_CR37","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/obr.12674","volume":"19","author":"KM Di Sebastiano","year":"2018","unstructured":"Di Sebastiano KM, Pinthus JH, Duivenvoorden WCM, et al. Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise. Obes Rev. 2018;19:1008\u201316.","journal-title":"Obes Rev"},{"key":"13839_CR38","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/jnci\/djp260","volume":"101","author":"D Albanes","year":"2009","unstructured":"Albanes D, Weinstein SJ, Wright ME, et al. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst. 2009;101:1272\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"13839_CR39","first-page":"650","volume":"9","author":"AB Opoku-Acheampong","year":"2019","unstructured":"Opoku-Acheampong AB, Baumfalk DR, Horn AG, et al. Prostate cancer cell growth characteristics in serum and prostate-conditioned media from moderate- intensity exercise-trained healthy and tumor-bearing rats. Am J Cancer Res. 2019;9:650\u201367.","journal-title":"Am J Cancer Res"},{"key":"13839_CR40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ijc.30803","volume":"141","author":"BA Dickerman","year":"2017","unstructured":"Dickerman BA, Ahearn TU, Giovannucci E, et al. Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. Int J Cancer. 2017;141:933\u201344.","journal-title":"Int J Cancer"},{"key":"13839_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/ije\/dyac124","volume":"52","author":"EL Watts","year":"2023","unstructured":"Watts EL, Perez-Cornago A, Fensom GK, et al. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol. 2023;52:71\u201386.","journal-title":"Int J Epidemiol"},{"key":"13839_CR42","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-15-1551","volume":"76","author":"RC Travis","year":"2016","unstructured":"Travis RC, Appleby PN, Martin RM, et al. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016;76:2288\u2013300.","journal-title":"Cancer Res"},{"key":"13839_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1530\/EC-13-0086","volume":"3","author":"D Weinstein","year":"2014","unstructured":"Weinstein D, Sarfstein R, Laron Z, et al. Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells. Endocr Connect. 2014;3:24\u201335.","journal-title":"Endocr Connect"},{"key":"13839_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113615","volume":"19","author":"V Vella","year":"2018","unstructured":"Vella V, Milluzzo A, Scalisi NM, et al. Insulin Receptor Isoforms in Cancer. Int J Mol Sci. 2018;19: 3615.","journal-title":"Int J Mol Sci"},{"key":"13839_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/rmb2.12039","volume":"16","author":"T Yanase","year":"2017","unstructured":"Yanase T, Kawanami T, Tanaka T, et al. Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives. Reprod Med Biol. 2017;16:252\u20137.","journal-title":"Reprod Med Biol"},{"key":"13839_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154358","volume":"11","author":"GP P\u00fcschel","year":"2022","unstructured":"P\u00fcschel GP, Klauder J, Henkel J. Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases. J Clin Med. 2022;11: 4358.","journal-title":"J Clin Med"},{"key":"13839_CR47","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","volume":"127","author":"TA Claushuis","year":"2016","unstructured":"Claushuis TA, van Vught LA, Scicluna BP, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood. 2016;127:3062\u201372.","journal-title":"Blood"},{"key":"13839_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000444807","volume":"43","author":"JB Kral","year":"2016","unstructured":"Kral JB, Schrottmaier WC, Salzmann M, Assinger A. Platelet Interaction with Innate Immune Cells. Transfus Med Hemother. 2016;43:78\u201388.","journal-title":"Transfus Med Hemother"},{"key":"13839_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","volume":"23","author":"M Scherlinger","year":"2023","unstructured":"Scherlinger M, Richez C, Tsokos GC, Boilard E, Blanco P. The role of platelets in immune-mediated inflammatory diseases. Nat Rev Immunol. 2023;23:495\u2013510.","journal-title":"Nat Rev Immunol"},{"key":"13839_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153833","volume":"20","author":"T Cai","year":"2019","unstructured":"Cai T, Santi R, Tamanini I, et al. Current Knowledge of the Potential Links between Inflammation and Prostate Cancer. Int J Mol Sci. 2019;20: 3833.","journal-title":"Int J Mol Sci"},{"key":"13839_CR51","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Marabelle A, Eggermont A, et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27:1482\u201392.","journal-title":"Ann Oncol"},{"key":"13839_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117690","volume":"552","author":"S Najafi","year":"2024","unstructured":"Najafi S, Asemani Y, Majidpoor J, Mahmoudi R, et al. Tumor-educated platelets. Clin Chim Acta. 2024;552: 117690.","journal-title":"Clin Chim Acta"},{"key":"13839_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1121401","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Zhu C, Pan F, et al. Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Front Oncol. 2023;13: 1121401.","journal-title":"Front Oncol"},{"key":"13839_CR54","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.4252\/wjsc.v12.i11.1237","volume":"12","author":"G Mendoza-Almanza","year":"2020","unstructured":"Mendoza-Almanza G, Burciaga-Hern\u00e1ndez L, Maldonado V, et al. Role of platelets and breast cancer stem cells in metastasis. World J Stem Cells. 2020;12:1237\u201354.","journal-title":"World J Stem Cells"},{"key":"13839_CR55","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2016-11-751099","volume":"130","author":"JV Michael","year":"2017","unstructured":"Michael JV, Wurtzel JGT, Mao GF, et al. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood. 2017;130:567\u201380.","journal-title":"Blood"},{"key":"13839_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.939089","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Wang X, Guo E, et al. Emerging roles of platelets in cancer biology and their potential as therapeutic targets. Front Oncol. 2022;12: 939089.","journal-title":"Front Oncol"},{"key":"13839_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119612","volume":"277","author":"N Pavlovi\u0107","year":"2021","unstructured":"Pavlovi\u0107 N, Kopsida M, Gerwins P, et al. Activated platelets contribute to the progression of hepatocellular carcinoma by altering the tumor environment. Life Sci. 2021;277: 119612.","journal-title":"Life Sci"},{"key":"13839_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/cancers11030277","volume":"11","author":"KL Clar","year":"2019","unstructured":"Clar KL, Hinterleitner C, Schneider P, et al. Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL. Cancers (Basel). 2019;11:277.","journal-title":"Cancers (Basel)"},{"key":"13839_CR59","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.7150\/thno.64252","volume":"12","author":"A Rodriguez-Martinez","year":"2022","unstructured":"Rodriguez-Martinez A, Simon-Saez I, Perales S, et al. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior. Theranostics. 2022;12:2150\u201361.","journal-title":"Theranostics"},{"key":"13839_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020623","volume":"21","author":"C Barale","year":"2020","unstructured":"Barale C, Russo I. Influence of Cardiometabolic Risk Factors on Platelet Function. Int J Mol Sci. 2020;21: 623.","journal-title":"Int J Mol Sci"},{"key":"13839_CR61","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","volume":"3","author":"O Leiva","year":"2021","unstructured":"Leiva O, AbdelHameid D, Connors JM, et al. Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2021;3:619\u201334.","journal-title":"JACC CardioOncol"},{"key":"13839_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2019.153946","volume":"99","author":"JR Sowers","year":"2019","unstructured":"Sowers JR, Habibi J, Aroor AR, et al. Epithelial sodium channels in endothelial cells mediate diet-induced endothelium stiffness and impaired vascular relaxation in obese female mice. Metabolism. 2019;99:57\u201366.","journal-title":"Metabolism"},{"key":"13839_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154223","volume":"109","author":"JR Sowers","year":"2020","unstructured":"Sowers JR, Habibi J, Jia G, et al. Endothelial sodium channel activation promotes cardiac stiffness and diastolic dysfunction in Western diet fed female mice. Metabolism. 2020;109: 154223.","journal-title":"Metabolism"},{"key":"13839_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphys.2015.00335","volume":"6","author":"NL Sehgel","year":"2015","unstructured":"Sehgel NL, Vatner SF, Meininger GA. \u201cSmooth Muscle Cell Stiffness Syndrome\u201d-Revisiting the Structural Basis of Arterial Stiffness. Front Physiol. 2015;6:335.","journal-title":"Front Physiol"},{"key":"13839_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.851941","volume":"13","author":"M Wang","year":"2022","unstructured":"Wang M, Li Y, Li S, et al. Endothelial Dysfunction and Diabetic Cardiomyopathy. Front Endocrinol (Lausanne). 2022;13: 851941.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13839_CR66","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1753-0407.12521","volume":"9","author":"Y Shi","year":"2017","unstructured":"Shi Y, Vanhoutte PM. Macro-and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9:434\u201349.","journal-title":"J Diabetes"},{"key":"13839_CR67","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.2174\/1381612827666210303143442","volume":"27","author":"LJB Malhab","year":"2021","unstructured":"Malhab LJB, Saber-Ayad MM, Al-Hakm R, et al. Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation. Curr Pharm Des. 2021;27:2156\u201369.","journal-title":"Curr Pharm Des"},{"key":"13839_CR68","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1038\/onc.2011.447","volume":"31","author":"H Werner","year":"2012","unstructured":"Werner H. Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. Oncogene. 2012;31:2703\u201314.","journal-title":"Oncogene"},{"key":"13839_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-016-0477-3","volume":"15","author":"N Beneit","year":"2016","unstructured":"Beneit N, Fern\u00e1ndez-Garc\u00eda CE, Mart\u00edn-Ventura JL, et al. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR\/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis. Cardiovasc Diabetol. 2016;15:161.","journal-title":"Cardiovasc Diabetol"},{"key":"13839_CR70","doi-asserted-by":"publisher","first-page":"H730","DOI":"10.1152\/ajpheart.00064.2020","volume":"319","author":"Y Higashi","year":"2020","unstructured":"Higashi Y, Sukhanov S, Shai SY, et al. Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe-deficient mice. Am J Physiol Heart Circ Physiol. 2020;319:H730\u201343.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"13839_CR71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaccao.2020.12.003","volume":"3","author":"ES Lau","year":"2021","unstructured":"Lau ES, Paniagua SM, Liu E, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3:48\u201358.","journal-title":"JACC CardioOncol"},{"key":"13839_CR72","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2020.12.030","volume":"79","author":"BC Fu","year":"2021","unstructured":"Fu BC, Tabung FK, Pernar CH, et al. Insulinemic and inflammatory dietary patterns and risk of prostate cancer. Eur Urol. 2021;79:405\u201312.","journal-title":"Eur Urol"},{"key":"13839_CR73","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1158\/1055-9965.EPI-22-0147","volume":"31","author":"CS Langlais","year":"2022","unstructured":"Langlais CS, Graff RE, Van Blarigan EL, et al. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality. Cancer Epidemiol Biomarkers Prev. 2022;31:1760\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13839_CR74","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/EJE-16-0200","volume":"175","author":"AS Cheung","year":"2016","unstructured":"Cheung AS, Hoermann R, Dupuis P, et al. Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer. Eur J Endocrinol. 2016;175:229\u201337.","journal-title":"Eur J Endocrinol"},{"key":"13839_CR75","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euf.2018.02.007","volume":"5","author":"SD Brookman-May","year":"2019","unstructured":"Brookman-May SD, Campi R, Henr\u00edquez JDS, et al. Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). Eur Urol Focus. 2019;5:756\u201387.","journal-title":"Eur Urol Focus"},{"key":"13839_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ijc.34898","volume":"155","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Stopsack KH, Song M, et al. Healthy dietary patterns and risk of prostate cancer in men at high genetic risk. Int J Cancer. 2024;155:71\u201380.","journal-title":"Int J Cancer"},{"key":"13839_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/fon-2016-0217","volume":"13","author":"M Ferro","year":"2017","unstructured":"Ferro M, Terracciano D, Buonerba C, et al. The emerging role of obesity, diet and lipid metabolism in prostate cancer. Future Oncol. 2017;13:285\u201393.","journal-title":"Future Oncol"},{"key":"13839_CR78","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s41043-024-00578-4","volume":"43","author":"M Mahmoodi","year":"2024","unstructured":"Mahmoodi M, Gabal BC, Mohammadi F, et al. The association between healthy and unhealthy dietary indices with prostate cancer risk: a case-control study. J Health Popul Nutr. 2024;43:90.","journal-title":"J Health Popul Nutr"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13839-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13839-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13839-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T18:02:56Z","timestamp":1745863376000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13839-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13839"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13839-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research adhered to the Declaration of Helsinki. This study was approved by Ethics Committee of First Affiliated Hospital of Xinjiang Medical University (Ethical Application: 20220308\u2013166). All participants provided informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"795"}}